- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04119414
Like Father Like Son
July 18, 2023 updated by: Stephen Weiss, University of Miami
Increasing Early Infant Male Circumcision Uptake in Zambia: Like Father Like Son
This purpose of this study is to look at the best way to offer the Like Father Like Son + Spear & Shield program.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
600
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lusaka, Zambia
- Lusaka Province Community Health Clinics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Men and women must be able to understand and sign the Informed Consent in English or local language.
- All participants must be adults able to provide consent
- Women participants may be pregnant
- Individuals not yet adults (infants, children, teenagers) are not eligible to participate
- Prisoners will not be eligible for recruitment
Exclusion Criteria:
- Participants not meeting any of the inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: S&S + LFLS Group
300 expecting couples totaling 600 participants will be completing the S&S program followed by the LFLS Program.
|
The S&S Program is a comprehensive sexual risk reduction intervention consisting of 4 weekly 90-minute manualized group sessions conducted by a trained Community Health Center (CHC) facilitator.
The LFLS Program is a private 2 90-minute session conducted by a trained CHC facilitator.
The sessions will be focused on exploring issues relevant to parental decision making related to voluntary medical male circumcision (VMMC) and early infant male circumcision (EIMC).
Session 1 will be conducted antenatal and Session 2 will be immediately post-partum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Early Infant Male Circumcision
Time Frame: Up to 60 days of life
|
As measured by the number of male infants who received circumcision during the first 60 days of life
|
Up to 60 days of life
|
Number of Voluntary Medical Male Circumcision
Time Frame: Up to 12 months
|
Number of Voluntary Medical Male Circumcision (VMMC) of adult male participants within the total number of clinic patients being seen at each of the participating clinics.
|
Up to 12 months
|
Number of Parents' Who Indicate They Plan to Circumcise Their Infants
Time Frame: Up to 12 months
|
Number of parents who indicate they plan to circumcise their infants prior to infants being born.
|
Up to 12 months
|
Clinic Level (Cluster) Number of Early Infant Male Circumcision (EIMC)
Time Frame: 30 months
|
Clinic Level (Cluster) Number of EIMC within the total number of clinic patients being seen at each of the participating clinics
|
30 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Stephen Weiss, Ph.D., University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2019
Primary Completion (Actual)
June 30, 2022
Study Completion (Actual)
June 30, 2022
Study Registration Dates
First Submitted
October 6, 2019
First Submitted That Met QC Criteria
October 6, 2019
First Posted (Actual)
October 8, 2019
Study Record Updates
Last Update Posted (Actual)
August 2, 2023
Last Update Submitted That Met QC Criteria
July 18, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20190354
- R34MH121111 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Risk Behaviors
-
Istanbul University - Cerrahpasa (IUC)CompletedHealth Risk Behaviors | Reproductive Health | Sexual HealthTurkey
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaNot yet recruitingHealth Risk Behaviors
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University Medicine GreifswaldUniversity Hospital Schleswig-Holstein; Deutsche Krebshilfe e.V., Bonn (Germany) and other collaboratorsCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Laura RichardsonCompleted
-
University of Maryland Eastern ShoreCompletedHealth Risk Behaviors | Physical InactivityUnited States
-
University of CalgaryCanadian Institutes of Health Research (CIHR); British Columbia Farmers' Market...CompletedDiet, Healthy | Health Risk BehaviorsCanada
Clinical Trials on Spear and Shield (S&S) Program
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Cancer | SurvivorshipUnited States
-
Instituto Europeo de Estudios en PrevenciónUniversity of the Balearic Islands; University of Oviedo; University of Santiago...Active, not recruitingAlcohol Drinking | Behavior, Addictive | Substance Use | Smoking Behaviors | Illicit Drug UseSpain
-
Shiga UniversityUniversity of Chicago; Shionogi; Tokyo University; Showa University; Fukushima Medical... and other collaboratorsUnknown
-
University of RochesterNational Institute of Mental Health (NIMH)Recruiting
-
ShionogiCompletedHead and Neck Cancer | Esophageal Cancer | Lung Cancer | Mesothelioma | Bladder CancerUnited Kingdom
-
DSM Nutritional Products, Inc.Spaulding Clinical Research LLCCompletedAbsorption; Chemicals | Sunscreening AgentsUnited States
-
GlaxoSmithKlineCompleted
-
Abbott Medical DevicesActive, not recruitingSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
SolAeroMed Inc.RecruitingBronchiectasis | Cystic FibrosisCanada
-
National Institute of Allergy and Infectious Diseases...Gritstone bio, Inc.Completed